Sep 3, 2020 04:30PM Mirati Therapeutics To Participate In Citi's 15th Annual Biopharma Virtual Conference

Jan 9, 2020 09:27AM Pre-Open Stock Movers 01/09: (AXNX) (CHS) (DBVT) Higher (TUFN) (BBBY) (AYI) Lower (more...)

Aug 7, 2019 06:44AM Mirati Therapeutics (MRTX) PT Lowered to $130 at Citi

Jun 19, 2019 09:31AM Pre-Open Movers 06/19: (AXTA) (EROS) (JILL) Higher; (SESN) (QUIK) (LZB) (more...)

Jun 4, 2019 09:23AM Pre-Open Movers 06/04: (PTI) (APPS) (MRTX) Higher; (BOX) (SIEN) (VTR) (more...)

Jun 4, 2019 08:32AM UPDATE: Citi Upgrades Mirati Therapeutics (MRTX) to Buy on '849 Potential

May 16, 2019 08:50AM Mirati Therapeutics (MRTX) Gains Following Competitor ASCO Abstract

May 13, 2019 07:18AM Mirati Therapeutics (MRTX) PT Lowered to $76 at Citi

Mar 4, 2019 05:53AM Citi Downgrades Mirati Therapeutics (MRTX) to Neutral

Jan 22, 2019 04:01PM Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

Jan 17, 2019 09:31AM Pre-Open Stock Movers 01/17: (LPCN) (TA) (KNX) Higher; (SIG) (FUL) (MS) Lower (more...)

Jan 17, 2019 05:52AM Mirati Therapeutics (MRTX) Prices 1.61M Share Offering at $62/Sh

Jan 16, 2019 08:45PM Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock

Jan 16, 2019 05:34PM After-Hours Movers 1/16: (ADMP) (PCG) (FOLD) Higher; (FUL) (CSX) (MRTX) (more...)

Jan 16, 2019 04:02PM Mirati Therapeutics (MRTX) Announces Proposed $75M Share Common Offering

Jan 16, 2019 04:01PM Mirati Therapeutics Announces Proposed Public Offering Of Common Stock

Oct 22, 2018 09:32AM Pre-Open Movers 10/22: (ARII) (DVAX) (PETS) Higher; (MRTX) (HAS) (BMY) Lower (more...)

Aug 29, 2018 04:30PM Mirati Therapeutics To Participate In Oncology Panels At The 2018 Citi Biotech Conference

Jul 5, 2018 06:21AM Mirati Therapeutics (MRTX) PT Raised to $64 at Citi on Positive Interim Phase 2 Data for Sitra Plus Nivo; 'IO Refractory NSCLC Still Underappreciated'

Mar 5, 2018 06:28AM Mirati Therapeutics (MRTX) PT Raised to $37 at Citi

Dec 1, 2017 06:40AM Mirati Therapeutics (MRTX) PT Raised to $23 at Citi

Sep 19, 2017 05:32AM UPDATE: Mirati Therapeutics, Inc. (MRTX) PT Raised to $16 at Citi

Aug 30, 2017 04:15PM Mirati Therapeutics To Participate In Immuno-Oncology Panel Discussion At The 2017 Citi Biotech Conference

Jan 13, 2016 07:20AM Citi Upgrades Mirati Therapeutics (MRTX) to Buy

Nov 23, 2015 07:56AM Citi Starts Mirati Therapeutics (MRTX) at Neutral

Sep 16, 2015 06:57AM Mirati Therapeutics (MRTX) Prices 2.25M Common Stock Offering at $45/Share

Sep 15, 2015 08:35PM Mirati Therapeutics Announces Pricing Of Public Offering Of Common Stock

Sep 14, 2015 04:01PM Mirati Therapeutics (MRTX) to Offer $80M in Common Stock

Sep 14, 2015 04:01PM Mirati Therapeutics (MRTX) Announces $80M Common Stock Offering

Sep 14, 2015 04:01PM Mirati Therapeutics Announces Proposed Public Offering of $80 Million of Common Stock

Jun 1, 2015 10:42AM Notable Analyst Rating Changes 6/1: (C) (KO) (ABEV) Upgraded; (CLD) (JNPR) (MRTX) Downgraded

May 29, 2015 08:56AM Citi Starts Mirati Therapeutics (MRTX) at Buy